State and territorial health departments have resumed distributing monoclonal antibodies to clinical sites, the Department of Health and Human Services announced.
Novel Coronavirus (COVID-19) News
Below are links to AHA Today stories on novel coronavirus (COVID-19). For all coronavirus resources and news updates, visit our COVID-19 page.
Latest
The Centers for Disease Control and Prevention updated its guidance for health care personnel on preventing and controlling infections during the COVID-19 pandemic; managing health care personnel with SARS-CoV-2 infection or exposure; and preventing SARS-CoV-2 spread in nursing homes.
The Department of Health and Human Services announced that it will distribute $25.5 billion in COVID-19 relief funds to health care providers.
The Department of Health and Human Services took action to provide a pathway for all states and territories to increase access to critical COVID-19 monoclonal antibody therapeutics.
The Biden Administration announced an additional $452 million in federal funding through the Centers for Medicare & Medicaid Services to support 13 states’ efforts to improve access to health insurance through 1332 waivers.
The Centers for Medicare & Medicaid Services collected complete COVID-19 data from the vast majority of nursing homes in 2020, according to a new report from the Department of Health and Human Services’ Office of Inspector General.
According to new Centers for Disease Control and Prevention research, hospitalization for COVID-19 for children and adolescents increased four-fold in August in states with low levels of vaccination, compared with states with high levels.
The Department of Health and Human Services is making temporary changes to its distribution policies for monoclonal antibody therapies, with an eye on maintaining sufficient supply to meet current and future demand.
The Health Resources and Services Administration has released a fact sheet outlining specific acceptable personnel-related costs that can be covered by Provider Relief Fund dollars.
The Centers for Disease Control and Prevention alerted health care providers and the public to reports of severe illness associated with using products containing ivermectin to prevent or treat COVID-19.
The AHA released a new issue of the COVID-19 Snapshot, underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.
The COVID-19 pandemic has brought into focus more than ever before the need for teamwork and communication. To help support health care teams and get everyone on the same page, TeamSTEPPS is a practical, evidence-based set of communications tools developed over decades. It’s been implemented successfully across hospitals and health systems and is now taking on an even greater role with infection prevention and control teams as COVID-19 continues to spread.
Health care providers should stop using N95 respirators made by Shanghai Dasheng Health Products Manufacturing Co. Ltd., which are no longer authorized for emergency use, the Food and Drug Administration announced.
Moderna announced the completion of its biologic license application to the Food and Drug Administration for its mRNA COVID-19 vaccine. The application comes with a request for priority review.
The AHA released new public service announcements and related digital content encouraging vaccination against COVID-19 by still-unvaccinated health care workers and members of the public.
The Health Resources and Services Administration will host short briefings at 11 a.m. ET and 3 p.m. ET Aug. 26 to help hospitals and other health care providers who received Provider Relief Fund payments between April 10 and June 30, 2020, report by Sept. 30 on how they used the funds for health care-related expenses or lost revenues attributable to COVID-19 as required.
The Centers for Disease Control and Prevention released research highlighting two important trends emerging from the COVID-19 pandemic regarding vaccines’ current effectiveness.
On this episode, I discuss the COVID-19 pandemic and public health infrastructure with Mike Slubowski, president and CEO at Trinity Health, a Catholic health system that serves communities in 25 states.
The Food and Drug Administration granted full approval for the Pfizer-BioNTech COVID-19 vaccine for individuals age 16 and over.
An estimated 72% of the two largest commercial health insurers in each state and the District of Columbia are no longer waiving patient cost sharing for COVID-19 treatment, according to an analysis released by the Kaiser Family Foundation.